Exchange Transfusion

Transfusion exchange therapy (TET) is a therapeutic and diagnostic procedure aimed at restoring hematopoiesis in patients suffering from hemolytic anemia or severe poisoning with hemolytic poisons. This method consists of intravascular removal of hemolysates (poisonous compounds) and/or precursors (amino acids) of hemoglobin by collecting a certain amount of blood (usually up to

Transfusions are intended to treat many blood disorders. In this case, we are dealing with exchange transfusion, which helps to cope with hemolytic disease of the newborn. What kind of disease this is, how the exchange transfusion procedure occurs, and why it is effective will be discussed in this article.

Hemolytic disease of the newborn (GBV) is caused by incompatibility between the blood of mother and baby. This can happen if the mother carries antibodies to antigens in the newborn's blood, or if the newborn does not have enough of its own antibodies to fight attacking immune cells. If this infection does not resolve within 6 weeks after the baby is born, there is a risk of complications such as destruction of red blood cells and decreased hemoglobin levels.

Exchange transfusion is a treatment method used to relieve symptoms of GBV. With this method, the child's blood is replaced with the same amount of donor plasma. This procedure is performed in a hospital using syringes and a three-way stopcock. A syringe is used to draw blood from a baby through the umbilical cord. The blood is then removed from the syringe container and replaced with donor plasma that is compatible with the mother's blood. After several repetitions of the procedure, destroyed red blood cells, bilirubin (a breakdown product of red blood cells) and excess fluid are washed out of the body. In addition to hemoly